How did GlaxoSmithKline flourish in the financial ... What has changed to allow GSK to remain in this position of success? In times before the internet, corporations had secrets.

GlaxoSmithKline and Theravance have been marching right along. All four of their next-generation long-lasting treatments were approved by the FDA, offering hope that a successful product launch ...

GlaxoSmithKline's Nucala met its primary endpoint ... we've positioned ourselves for success. And we share that positioning and all the analysis behind it with our members. Analyst’s Disclosure ...

Read our privacy notice. GlaxoSmithKline's global head of yax, Melissa Geiger, shares the secrets to her success, including staying one step ahead of a fast-moving industry and switching off with ...

GlaxoSmithKline PLC is a pharmaceutical giant ... the GSK and Novartis Consumer businesses’ joint venture with great success. The EMpower 50 Advocates Role Models 2022 named Diana Conrad as ...

Pfizer and Shionogi only own 13.5% and 10%, respectively, of ViiV, but the success of ViiV still contributes favorably to all of their bottom-lines. GlaxoSmithKline has to be thrilled with the ...

The lawsuit claims GlaxoSmithKline replaced Flovent with an identical generic version, hurting patients whose insurance wouldn't cover it and costing taxpayers money. Arizona Attorney General Kris ...

Spero Therapeutics and partner GSK are stopping a late-stage trial of an experimental oral drug for complicated urinary tract infections early as the study met its main goal, the companies said on ...